A risk factor is something that increases your likelihood of getting a disease or condition.
It is possible to develop
with or without the risk factors listed below. However, the more risk factors you have, the greater your likelihood of developing non-Hodgkins lymphoma. If you have a number of risk factors, ask your doctor what you can do to reduce your risk.
Risk factors include:
Non-Hodgkins lymphoma seems to occur more often in people who:
Have had chronic infections, such as Epstein-Barr virus, hepatitis C, and
- Have autoimmune and chronic inflammatory conditions such as systemic lupus erythematosus, rheumatoid arthritis, celiac disease, and Sjogren's syndrome
Some non-Hodgkins lymphomas are associated with the use of immunosuppressive drugs that are used to prevent transplant rejection. These drugs weaken your immune system response.
The chance of developing non-Hodgkin’s lymphoma increases with age.
Men are more likely than women to develop non-Hodgkins lymphoma.
People who work around pesticides, fertilizers, and solvents have a greater chance of developing non-Hodgkins lymphoma than people who do not have this exposure.
People with significant exposure to radiation, such as survivors of nuclear explosions or accidents or those exposed to radon gas, are more likely to develop lymphoma. Therapeutic
do not increase the risk of lymphoma.
People who have a parent with non-Hodgkins lymphoma may have an increased risk of developing this cancer. This is especially true if the family member had it at an early age.
Lymphoma. The Leukemia & Lymphoma Society
website. Available at:
. Updated April 19, 2013. Accessed April 29, 2013.
Non-Hodgkin lymphoma. National Cancer Institute
website. Available at:
. Accessed April 29, 2013.
2/5/2013 DynaMed's Systematic Literature Surveillance
: Kharazmi E, Fallah M, et al. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ. 2012;345:e8076.
7/7/2014 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Liang Y, Yang Z, et al. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014 Jun;73(6):1151-1156.
Last reviewed April 2013 by Mohei Abouzied, MD;
Michael Woods, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.